24 December 2025

Awareness Circular (24 ) – Waring about using the falsified Product Orforglipron

Reference: CIR-2025-00000233

Waring about using the falsified Product Orforglipron

To all Health facilities and healthcare practitioners in Dubai's private health sector

 

Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the MOHAP for perusal and adherence to what is stated.

 

Awareness Circular – Waring about using the falsified Product Orforglipron

 

Thanks in advance for your good co-operation

 

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Circular no. 24 - Awareness Circular - Waring about using the falsified Product Orforglipron .pdf:

View Document